Form 4: Encompass Health Director Acquires Additional Shares Through Dividend Reinvestment

Greg D. Carmichael, a director at Encompass Health Corp, acquired 24 shares of common stock due to a dividend reinvestment program.

Summary

• On July 15, 2024, Greg D. Carmichael, a director of Encompass Health Corp, acquired 24 shares of Encompass Health common stock.
• The acquisition was a result of a dividend reinvestment related to outstanding restricted stock units (RSUs).
• Encompass Health paid a dividend of $0.15 per share on its common stock on July 15, 2024, with a closing price of $85.49.
• Following the transaction, Carmichael directly owns 17,074 shares of Encompass Health common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to a routine transaction (dividend reinvestment). It doesn't convey any particularly positive or negative sentiment about the company's performance or prospects.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions and reflects standard practices for directors receiving stock through dividend reinvestment programs. It doesn't necessarily indicate a significant shift in the company's outlook or strategy.

Comparison to Industry Standards

• Dividend reinvestment programs are a common practice among publicly traded companies, including those in the healthcare sector like Universal Health Services and HCA Healthcare.
• Director ownership and stock acquisitions through such programs are typical and align with industry standards for aligning management interests with shareholder value.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It reflects a director's continued investment in the company, which can be viewed positively by shareholders.

Key Dates